NIP: Issues/Rotavirus/main page

NIP:

NIP HOME

First time visitor?

About NIP

Data and Statistics

International Efforts

Links to other web sites

Glossary/ Acronyms

NIP sub-sites:

ACIP

Flu Vaccine

Immunization Registries

Vaccines for Children Program

CASA (Clinic Assessment Program)

AFIX (Grantee Assessment)

VACMAN

National Immunization Hotline

English
(800)232-2522

Spanish
(800)232-0233

TTY
(800)243-7889

Get Adobe Reader

Issues of Interest > Rotavirus
Rotavirus Vaccine (RotaShield^�) and Intussusception

The Advisory Committee on Immunization Practices (ACIP) voted on October 22, 1999 to no longer recommend use of the RotaShield^� vaccine for infants because of an association between the vaccine and intussusception. Article in the November 1999 MMWR

CDC published "Suspension of Rotavirus Vaccine After Reports of
Intussusception--United States, 1999" in the September 3, 2004 issue of Morbidity and Mortality Weekly Report (MMWR).

An October 1999 announcement showing that Wyeth-Lederle Vaccines voluntarily withdrew its RotaShield^� vaccine from the market and requested the immediate return of all doses of the vaccine.

	Rotavirus diarrhea remains a serious health concern for young children in the United States. Without a vaccine, it is very important that parents and health care providers quickly recognize and treat severe cases of childhood diarrhea. More information on Rotavirus...
	Rotavirus Fact Sheet

Intussusception Q&A

	Questions and answers about RotaShield^� vaccine and Intussusception
	CDC announced the start of a national education program to manage severe diarrhea in children.
	Consult your health care provider for more information on the treatment of severe diarrhea in children.

For more information contact

National Immunization Hotline:
English (800) 232-2522
Spanish (800) 232-0233

Top of page

This page last modified on October 14, 2004

Department of Health and Human Services
Centers for Disease Control and Prevention
CDC Home | CDC Search | CDC Health Topics A-Z